PBYI CIK: 1401667

Puma Biotechnology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.14
FY22:
0.13
FY23:
0.16
FY24:
0.15
FY25:
0.16
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.09
FY23:
0.07
FY24:
0.07
FY25:
0.05
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.22
FY23:
0.23
FY24:
0.21
FY25:
0.22

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.08
FY23:
0.10
FY24:
0.10
FY25:
0.08
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.12
FY23:
0.08
FY24:
0.03
FY25:
0.00
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.02
FY23:
0.05
FY24:
0.09
FY25:
0.13
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.22
FY23:
0.23
FY24:
0.21
FY25:
0.22

All amounts in billions USD Data source:SEC EDGAR